Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12214055 | Systems and methods for treating hyper-igm syndrome | Cecillia Cotta-Ramusino, Carrie Marie Margulies, Luigi Naldini | 2025-02-04 |
| 11964027 | Method for improving retroviral transduction and gene editing in hematopoietic stem cells using cyclosporine h (CsH) | Anna Christina Kajaste-Rudnitski, Carolina PETRILLO, Bernhard Rudolf Gentner, Luigi Naldini, Giulia Schiroli | 2024-04-23 |
| 11439666 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Philip D. Gregory, Michael C. Holmes, Luigi Naldini, David Paschon +2 more | 2022-09-13 |
| 10918668 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Philip D. Gregory, Michael C. Holmes, David Paschon, Lei Zhang, Maria Chiara Bonini +3 more | 2021-02-16 |
| 10155011 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Philip D. Gregory, Michael C. Holmes, Luigi Naldini, David Paschon +2 more | 2018-12-18 |
| 10117899 | Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells | Philip D. Gregory, Michael C. Holmes, Angelo Leone Lombardo, Luigi Naldini | 2018-11-06 |
| 9937207 | Targeted disruption of T cell receptor genes using talens | Philip D. Gregory, Michael C. Holmes, David Paschon, Lei Zhang, Maria Chiara Bonini +3 more | 2018-04-10 |
| 8956828 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Philip D. Gregory, Michael C. Holmes, Luigi Naldini, David Paschon +2 more | 2015-02-17 |